In-home Cycling for Individuals With PD: Feasibility

January 31, 2025 updated by: University of Wisconsin, Madison

Examining the Reach, Effectiveness and Maintenance of Social Engagement on Exercise Outcomes: In-home Cycling for Individuals With Parkinson Disease

This study will examine the influence of social support on exercise frequency, duration, quality of life, and overall activity level.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The benefits of exercise for individuals with Parkinson disease (PD) have been well documented; however, individuals with PD living in rural and underserved urban settings are largely unable or unwilling to participate in group exercise programs due in large part to their distance from such programs and financial considerations. Additionally, community based programs which provide social support and engagement have been shown to benefit elderly individuals as well as individuals with pathology, but are equally unattainable to this group. Taking the exercise to these individuals via telemedicine or tele-exercise may be an ideal means of delivering this type of intervention.

The long-term goal of this project is to improve outcomes for underserved populations of individuals with Parkinson disease (PD) by providing access to in-home physical activity via a telehealth approach. Approximately one million Americans currently live with a diagnosis of PD and it has been estimated that delaying the progression by 20% would result in a $75,891 savings per individual based on reduced health care costs, income maintenance, increased duration of life and improved quality of life. However, individuals with PD of lower socioeconomic status, people of color and rural dwelling seniors have been critically underserved by clinical and academic programming resulting in poorer health outcomes.

This Study will examine the effects of social engagement during in-home exercise on a small sample of individuals with Parkinson Disease (PD). This pilot investigation will directly measure the effect of social support and engagement on exercise outcomes for rural dwelling individuals with PD.

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wisconsin
      • Madison, Wisconsin, United States, 53705
        • University of Wisconsin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • diagnosis of idiopathic "definite PD" based upon established criteria
  • vision at or corrected to 20/40 or better
  • ability to independently ambulate for at least 10 minutes continuously
  • no reported vestibular or neurological disease (stroke or muscle disease) beyond their diagnosed PD
  • score of greater than or equal to 78 (no evidence of dementia) on the telephone adaptation of the modified mini-mental state exam
  • English Speaking

Exclusion Criteria:

  • contraindication for exercise
  • history of muscular or orthopedic diagnosis
  • inability to participate in the full duration of the study
  • currently exercising for 20 or more minutes per week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Social Cycling Group
Exercise bike delivered to their home, custom fit to their needs and installed in a safe location, sessions will consist of up to 30 minutes of cycling while engaged in social interaction with a research staff member, thus providing a social/community aspect that would not otherwise be present.
engaged with a research staff member for 30 minutes of cycling
No Intervention: Solo Cycling Control Group
Exercise bike delivered to their home, custom fit to their needs and installed in a safe location. Participants will be provided with exercise recommendations, but will receive only data recording calls every 2-weeks. [will crossover and complete the cycling intervention following the initial 6-months]

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence: Percentage of Sessions Completed
Time Frame: up to 6 months of active intervention
Total number of completed sessions divided by the prescribed number of sessions per study protocol (72)
up to 6 months of active intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time Per Session
Time Frame: up to 6 months of active intervention
The number of minutes spent cycling during each session
up to 6 months of active intervention
Adverse Events
Time Frame: up to 6 months of active intervention
Adverse events that occur during the active intervention period
up to 6 months of active intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fall Frequency
Time Frame: baseline, post-test (~6-months)
The Fall History Questionnaire is a 6-item survey that asks about Fall rate in the last 2 weeks, last month, last 6 months, the typical cause of a fall, and how the fear of falling may influence daily activities. The hypothesis is that Fall frequency will be improved in the socially engaged cycling group and not with those cycling alone.
baseline, post-test (~6-months)
Overall Activity Level as Measured by Average Steps Per Day
Time Frame: up to 6 months
Participant will wear an activity monitor to collect this data
up to 6 months
Change in Canadian Occupational Performance Measure (COPM) Scores
Time Frame: baseline, post-test (~6-months)
The Canadian Occupational Performance Measure (COPM) will be administered to assess the participant's self-report of performance and satisfaction on a scale of 1 to 10 on self-selected occupational tasks. Performance and satisfaction scores range from 1 (lowest) to 10 (highest) for each identified item. The top three identified occupations will be reported.
baseline, post-test (~6-months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kristen A Pickett, PhD, University of Wisconsin, Madison

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 25, 2021

Primary Completion (Actual)

January 4, 2024

Study Completion (Actual)

January 4, 2024

Study Registration Dates

First Submitted

March 5, 2020

First Submitted That Met QC Criteria

March 5, 2020

First Posted (Actual)

March 9, 2020

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 31, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2018-0414: Feasibility
  • A176000 (Other Identifier: UW Madison)
  • 1UL1TR002373-01 (U.S. NIH Grant/Contract)
  • EDUC\KINESIOLOGY\KINESIO (Other Identifier: UW Madison)
  • 1KL2TR002374-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Dr. Pickett will be responsible for deciding when/to whom to disseminate coded data, and will work with other researchers if necessary to confirm that they have proper IRB approval/etc., as necessary. Required UW-Madison IRB approval would be obtained prior to the release of any data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Social Cycling Group

Subscribe